These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11818471)

  • 21. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.
    Evans TG; Frey S; Israel H; Chiu J; El-Habib R; Gilbert P; Gaitan A; Montefiori DC;
    Vaccine; 2004 Jun; 22(20):2626-30. PubMed ID: 15193388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA vaccines against human immunodeficiency virus type 1.
    Estcourt MJ; McMichael AJ; Hanke T
    Immunol Rev; 2004 Jun; 199():144-55. PubMed ID: 15233732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward an antibody-based HIV-1 vaccine.
    Hoxie JA
    Annu Rev Med; 2010; 61():135-52. PubMed ID: 19824826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
    Calarota SA; Weiner DB; Lori F; Lisziewicz J
    Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 vaccine clinical trials: the Brazilian experience.
    Ersching J; Pinto AR
    Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS vaccine: present status and future challenges.
    Nigam PK; Kerketta M
    Indian J Dermatol Venereol Leprol; 2006; 72(1):8-18. PubMed ID: 16481703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity.
    Wren L; Kent SJ
    Hum Vaccin; 2011 Apr; 7(4):466-73. PubMed ID: 21389779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.
    Rubens M; Ramamoorthy V; Saxena A; Shehadeh N; Appunni S
    J Immunol Res; 2015; 2015():560347. PubMed ID: 26579546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection from HIV infection or AIDS?
    Miedema F; Meyaard L; Klein MR
    Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627
    [No Abstract]   [Full Text] [Related]  

  • 34. [HIV vaccine: how far along are we?].
    Reiss EIMM; van Gils MJ; Sanders RW; de Bree GJ
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.
    Koff WC; Russell ND; Walport M; Feinberg MB; Shiver JW; Karim SA; Walker BD; McGlynn MG; Nweneka CV; Nabel GJ
    Vaccine; 2013 Apr; 31 Suppl 2():B204-8. PubMed ID: 23598483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS: is there an answer to the global pandemic? The immune system in HIV infection and control.
    Maplanka C
    Viral Immunol; 2007 Sep; 20(3):331-42. PubMed ID: 17931104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HIV vaccines].
    Pialoux G; Slama L
    Presse Med; 2005 Nov; 34(20 Pt 2):1592-6. PubMed ID: 16314820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A brief history of the global effort to develop a preventive HIV vaccine.
    Esparza J
    Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analytic and integrative perspectives for HIV vaccine design].
    Yamamoto H
    Uirusu; 2013; 63(2):219-32. PubMed ID: 25366056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.